Диссертация (1174236), страница 18
Текст из файла (страница 18)
Dyer,R. McGilvray, V. Robertson, D. Turner // Mol. Immunol. – 2013. – Vol. 55. –Р. 2-7.73.Eisen, E.A. Healthy worker effect in a longitudinal study of one-second forcedexpiratory volume (FEV1) and chronic exposure to granite dust / E.A. Eisen,D.H. Wegman, Т.А. Louis et al. // Int. J. Epidemiol. – 1995. – Vol. 24. – № 6. –Р. 1154-1161.74.Enelow, R.I.
Structural and functional consequences of alveolar cell recognitionby CD8 (+) T lymphocytes in experimental lung disease / R.I. Enelow,A.Z. Mohammed, М. Н. Stoler et al. // J. Clin. Invest. – 1998. – V. 102. –Р. 1653-1661.75.Feghali-Bostwick, C.A. Autoantibodies in patients with chronic obstructivepulmonary disease / С.А. Feghali-Bostwick, A.S. Gadgil, L.E. Otterbein et al. //Am. J.
Respir. Crit. Care Med. – 2008. – Vol.177. – Р.156-163.76.Ferhani, N. Expression of highmobility group box 1 and of receptor for advancedglycation end products in chronic obstructive pulmonary disease / N. Ferhani,S. Letuve, A. Kozhich. еt al. // Am. J. Respir. Crit. Care Med. – 2010. – Vol.181.– Р. 917-927.77.Ferrarotti, I. COPD: no gene left unturned / I. Ferrarotti, М.С. Luisetti // LancetRespir. Med.
– 2014. –Vol. 2. – № 3. – Р.171-172.11178.Fujii, S. Insufficient autophagy promotes bronchial epithelial cell senescence inchronic obstructive pulmonary disease / S. Fujii, Н. Hara, J. Araya et al. //Oncoimmunology. – 2012. – Vol.1. – № 5. – Р.630-641.79.Global Initiative for Chronic Obstructive Lung disease. WHO, updated 2006.80.Global strategy for the diagnosis, management, and prevention of chronicobstructive pulmonary disease: Updated 2013 – Global Initiative for ChronicObstructive Lung Disesase, Inc.
– 2013. — 76 p.81.Greenlee, K. J. Matrix metalloproteinases in lung: multiple, multifarious, andmultifaceted / K. J. Greenlee, Z. Werb, F. Kheradmand // Physiol Rev. – 2007. –Vol. 87. – №1 – Р. 69-98.82.Guan, S. Ginsenoside Rg1 Ameliorates Cigarette Smoke-Induced AirwayFibrosis by Suppressing the TGF- β1 / Smad Pathway In Vivo and In Vitro/ S.
Guan , Q. Liu , F. Han et al. // Biomed. Res. Int. 2017; 2017:6510198. doi:10.1155/2017/6510198. Epub 2017 Mar 21.83.Guo, L. WNT/β-catenin signaling regulates cigarettesmoke-induced airwayinflammation via the PPARд / p38 pathway / L. Guo, T. Wang, Y. Wu et al. //Lab. Invest. – 2016.
– Vol. 96. – № 2. – Р. 218-229.84.Hansen, J.E. Discriminating measures and normal values for expiratoryobstruction / J.E. Hansen, X.G. Sun, К. Wasserman // Chest. – 2006. – Feb. –V. 129. – № 2. – Р. 369-377.85.Hawari, F.I. The effect of habitual waterpipe tobacco smoking on pulmonaryfunction and exercise capacity in young healthy males: A pilot study/ F.I. Hawari, N.A. Obeidat, I.M. Ghonimat et al. // Respir Med. – 2017. –Vol. 122. – Р. 71.86.Hilty, M.
Disordered microbial communities in asthmatic airways / М. Hilty,С. Burke, Н. Pedro et al. // PLoS One. – 2010. –Vol. 5. – № 1. – Р. e8578.87.Hnizdo, E. Chronic obstructive pulmonary disease due to occupational exposureto silica dust: a review of epidemiological and pathological evidence / E.
Hnizdo,V. Vallyathan // Occup. Environ. Med. – 2003. – Vol. 60. – № 4. – P. 237-243.11288.Hoenderdos, K. Hypoxia upregulates neutrophil degranulation and potential fortissue injury / K. Hoenderdos, K.M. Lodge, R.A. Hirst et al. // Thorax. – 2016. –Vol. 71. – № 11. – Р.1030-1038.89.Hogg, J.C. The nature of small-airway obstruction in chronic obstructivepulmonary disease / J.C. Hogg, F. Chu, S. Utokaparch et al. // N. Engl.
J. Med.– 2004. – Vol. 350. – P. 2645-2653.90.Holoshitz, J. The quest for better und erst and ing of HLA-disease association:scenes from aroadless travelled by / J. Holoshitz // Discov. Med. – 2013. –Vol.16. – Р. 93–101.91.Hong, Ch. Activated T cells secrete an alternatively spliced form of гc thatinhibits cytokine signaling and exacerbates inflammatory autoimmune disease/ Ch.Hong, A.M. Luckey, L.D. Ligons et al.
// Immunity. – 2014. – Vol. 40. –№ 6 – Р. 910-923.92.Hsieh, M.H. Lack of associations between several polymorphisms in cytokinegenes and the risk of chronic obstructive pulmonary diseases in Taiwan/ M.H. Hsieh, I.W. Chong, J.J. Hwang et al. // Kaohsiung J. Med. Sci. – 2008. –Vol. 24. – № 3. – P.126-137.93.Humerfelt, S. Association of years of occupational quartz exposure withspirometricair flowlimitation in Norwegian men aged 30–46 years/S.
Humerfelt, G. E. Eide, A. Gulsvik // Thorax. – 1998. – Vol. 53. – Р. 649-655.94.Hunt, S. HLA and the Maternal-Fetal Relationship. – USA-CANADA. – 1996.95.Hurst, J. R. Susceptibility to exacerbation in chronic obstructive pulmonarydisease / J.R. Hurst, J. Vestbo, A. Anzueto et al. // N. Engl. J. Med. – 2010.
–Vol. 363. – Р.1128-1138.96.Husebo, G. R. Growth differentiation factor-15 is a predictor of important diseaseoutcomes in patients with COPD / G.R. Husebo, R. Gronseth, L. Lerner et. al. //Eur. Respir. J. – 2017. – Vol. 49. – № 3. – P. ii1601298.97.Husebo, G. R. Macrophage migration inhibitory factor, a role in COPD /G.R.
Husebo, P.S. Bakke, R. Gronseth et. al. // Am. J. Physiol. Lung Cell Mol.Physiol. – 2016. – Vol. 311. – № 1. – P. L17.11398.Hutchison, D.C. Alpha1-antitrihsin deficiency. Genetic aspects of Alpha1antitrihsin deficiency: phenotypes and genetic modifiers of emphysema risk/ D. C. Hutchison, D. Cooper // Torax. – 2004. – Vol. 59. – P. 254-264.99.Isah, M. D. Spirometric evaluation of ventilatory function in adult male cigarettesmokers in Sokoto metropolis / M.
D. Isah, М. А. Makusidi, А. Abbas et al. //Niger Postgrad. Med. J. – 2017. – Vol. 24. – №1. – Р. 1-7.100. Janeway, C. A. Functions of the MHC: Presentation of Antigens to T-cells/ C. A. Janeway // Plenary report at ASH 23rd Annual Meeting, Atlanta, Georgia.– 1997. – P. 27-42.101. Johnsen, H. L. Production of silicon alloys is associated with respiratorysymptoms among employees in Norwegian smelters / Н.
Johnsen, V. Soyseth,S. M. Hetland et al. // Int. Arch. Occup. Environ Health. – 2008. – Vol. 81. –№ 4. – Р. 451-459.102. Joos, L. Genetic risk factors for chronic obstructive pulmonary disease / L. Joos,P. Pare, A. Sanford // Swiss.
Med. Wkly. – 2002. – Vol.132. – P. 27-37.103. Karayama, M. Anti end othe lial cell antibodies in patients with COPD /М. Karayama, N. Inui, Т. Suda et al. // Chest. – 2010. – Vol. 138. – Р.1303-1308.104. Kasuga, I. Lack of association of human leukocyte antigen-B7 with COPD andrate of decline in lung function / I. Kasuga, R.
Jian, J. Connett // Respiratorymedicine. – 2005. – Vol. 99. – P.1528-1533.105. Keicho, N. Contribution of HLA Genes to Genetic Predisposition in DiffusePanbronchiolitis / N. Keicho, K. Tokunaga, K. Nakata et al. // Am. J. Respir. Crit.Care Med. – 1998. – Vol. 158. – P. 846-850.106. Kent, L. Cigarette smoke extract induced cytokine and chemokine geneexpression changes in COPD macrophages / L. Kent, L. Smyth, C. Clayton et al.//Cytokine. – 2008.
– Vol. 42. – № 2. – P. 205–216.107. Kim, S. Identification of FAM13A gene associated with the ratio of FEV1 toFVC in Korean population by genome-wide association studies including geneenvironment interactions / S. Kim, H. Kim, N. Cho et al // J. Hum. Genet. – 2015.– Vol. 60. – № 3. – Р. 139-145.114108. Kim, V. New concepts in the pathobiology of chronic obstructive pulmonarydisease / V.
Kim , T. J. Rogers, G. J. Criner // Proc. Am. Thorac. Soc. – 2008. –Vol. 5. – № 4. – P. 478-485.109. Kirkham, Pa. Oxidative stress-induced antibodies to carbonyl-modified proteincorrelate with severity of chronic obstructive pulmonary disease / Pa. Kirkham,G. Caramori, Р. Casolari et al. // Am. J. Respir. Crit. Care Med. – 2011.
–Vol.184. – Р.796-802.110. Klein, J. The HLA system / J. Klein, А. Satо // N. Engl. J. Med. – 2000. –Vol.343 – Р. 782–786.111. Kobayashi, S.D. Neutrophils in the innate immune response / S.D. Kobayashi,J.M. Voyich, С. Burlak, F.R. DeLeo // Arch. Immunol. Ther. Exp. (Warsz). –2005.
– Vol. 53. – № 6. – Р. 505-517.112. Kobayashi, S.D. Role of neutrophils in innate immunity: a systems biology-levelapproach / S.D. Kobayashi, F.R. DeLeo // Wiley Interdiscip. Rev. Syst. Biol.Med. – 2009. – Vol. 1. – № 3. – Р. 309-333.113. Koo, H.K. Relationship between plasma matrixmetalloproteinase levels,pulmonary function, bronchodilator response, and emphysema severity /H.K. Koo, Y. Hong, M.N. Lim et al. // Int. J.
Chron. Obstruct. Pulmon. Dis. –2016. – Vol. 11. – Р. 1129-1137.114. Kraїm-Leleu, M. Occupational Risk Factors for COPD: A Case-Control Study/ М. Kraїm-Leleu, F.X. Lesage, М. Drame et al. // PLoS One. – 2016. –Vol. 11. – № 8. – P.e0158719.115. Kuo, Y-B. Identification and clinical association of anti-cytokeratin 18autoantibody in COPD / Y-B. Kuo, С.А.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
